SunWay Biotech Co., LTD. Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	301.02	293.71	362.19	123.57	346.44
Cash & Short-Term Investments	301.02	293.71	362.19	123.57	346.44
Cash Growth	2.49%	-18.91%	193.11%	-64.33%	17.30%
Accounts Receivable	278.38	298.3	266.47	170.66	102.45
Receivables	278.38	298.3	266.47	206.91	102.45
Inventory	190.16	210.03	170.23	94	76.91
Prepaid Expenses	9.61	15.46	9.13	12.26	2.84
Other Current Assets	8.51	7.99	4.74	3.83	-
Total Current Assets	787.67	825.48	812.76	440.56	528.63
Property, Plant & Equipment	340.88	337.12	319.45	5.43	48.64
Long-Term Investments	679.69	12.97	7.76	-	5.34
Goodwill	2,027	2,027	2,027	-	-
Other Intangible Assets	350.22	392.16	429.39	16.85	11.68
Long-Term Deferred Tax Assets	10.37	4.22	6.97	5.92	-
Other Long-Term Assets	266.27	193.76	136.53	9.47	13.41
Total Assets	4,462	3,792	3,740	478.23	607.7
Accounts Payable	28.13	51.54	35.72	57.96	18.59
Accrued Expenses	-	-	-	-	29.87
Short-Term Debt	200	-	7.51	65.56	-
Current Portion of Long-Term Debt	48.72	-	-	-	-
Current Portion of Leases	12.2	17.04	31.55	2.4	2.51
Current Income Taxes Payable	24.38	24.63	18.43	7.39	0.49
Current Unearned Revenue	21.77	13.65	15.89	14.95	0.84
Other Current Liabilities	149.68	116.57	94.3	38.84	8.34
Total Current Liabilities	484.88	223.44	203.4	187.1	60.65
Long-Term Debt	408.86	-	-	-	-
Long-Term Leases	214.95	226.95	248.3	3.05	-
Long-Term Unearned Revenue	23.18	-	-	-	-
Long-Term Deferred Tax Liabilities	66.13	75.08	82.24	-	-
Other Long-Term Liabilities	-	1.66	3.28	-	-
Total Liabilities	1,198	527.13	537.21	190.14	60.65
Common Stock	603.89	603.89	593.89	209.19	331.35
Additional Paid-In Capital	2,526	2,524	2,555	-	29.08
Retained Earnings	152.24	131.06	51.09	32.82	195.83
Treasury Stock	-20.99	-	-	-	-
Comprehensive Income & Other	-0.34	3.36	-0.68	46.08	-12.6
Total Common Equity	3,261	3,263	3,199	288.09	543.66
Minority Interest	2.59	2.6	2.89	-	3.39
Shareholders' Equity	3,264	3,265	3,202	288.09	547.05
Total Liabilities & Equity	4,462	3,792	3,740	478.23	607.7
Total Debt	884.73	243.99	287.35	71.01	2.51
Net Cash (Debt)	-583.7	49.71	74.84	52.57	343.93
Net Cash Growth	-	-33.57%	42.37%	-84.72%	17.42%
Net Cash Per Share	-9.68	0.82	2.44	2.60	10.01
Filing Date Shares Outstanding	60.39	60.39	60.39	34.11	33.69
Total Common Shares Outstanding	60.39	60.39	60.39	34.11	33.69
Working Capital	302.79	602.04	609.36	253.47	467.99
Book Value Per Share	54.00	54.03	52.98	8.44	16.14
Tangible Book Value	884.3	843.81	743.36	271.24	531.98
Tangible Book Value Per Share	14.64	13.97	12.31	7.95	15.79
Machinery	140.06	100.91	102.56	1.78	129.24
Construction In Progress	36.39	57.04	31.9	-	-
Leasehold Improvements	49.24	58.95	25.58	-	23.19